Medicago and GSK start Phase 3 trial of adjuvanted COVID-19 vaccine candidate
Read more - Medicago and GSK start Phase 3 trial of adjuvanted COVID-19 vaccine candidate Read more
Press releases
You will be able to find all of our recent and archived news announcements. Our press releases are intended for business journalists.
GSK named one of Canada’s Top 100 Employers in the year of the pandemic
Read more - GSK named one of Canada’s Top 100 Employers in the year of the pandemic Read more
Medicago and GSK announce start of Phase 2/3 clinical trials of adjuvanted COVID-19 vaccine candidate
GSK sets new environmental goals of net zero impact on climate and net positive impact on nature by 2030
New Study Concludes No Correlation Between NSAIDS — Including Ibuprofen — and Worsening COVID-19 Outcomes
ZEJULA is approved in Canada for first-line maintenance treatment of women with advanced ovarian cancer
Sanofi and GSK sign agreements with the Government of Canada to supply up to 72 million doses of adjuvanted COVID-19 vaccine
GSK announces first participant vaccinated in Phase 3 Clinical Trials of its 5-in-1, Meningitis ABCWY vaccine candidate
GSK and Medicago announce collaboration to develop a novel adjuvanted COVID-19 candidate vaccine
Voluntary disclosure of payments to healthcare professionals in 2019
Read more - Voluntary disclosure of payments to healthcare professionals in 2019 Read more